Seattle-based biotech company Athira Pharmaannounced a three-year grant totaling $15 million from the National Institute on Aging to support an upcoming clinical trial of a treatment that seeks to stop the deterioration of neurons and restore healthy brain activity in people with mild to moderate cases of Alzheimer’s disease. The grant from the NIA, part […]

Presentations during the virtual 62nd American Society of Hematology (ASH) Annual Meeting for the ongoing Phase 1 dose-escalation clinical trial with STRO-001, a CD74-targeted antibody-drug conjugate (ADC) developed by Sutro Biopharma and designed for the treatment of patients with late-line Non-Hodgkin Lymphoma (NHL), demonstrated that the investigational drug was generally well-tolerated in this patient population. […]

Relief Therapeutics and NeuroRx have met the patient enrollment target of 165 agreed with the US Food and Drug Administration (FDA) in the trial of RLF-100 (aviptadil), a formulation of Vasoactive Intestinal Polypeptide (VIP) for Covid-19. The ongoing Phase IIb/III trial is evaluating RLF-100 for treating respiratory failure in critical Covid-19 patients. According to the […]